New York – October 20, 2022 – Research Nester’s recent market research analysis on “Flash Glucose Monitoring Market: Global Demand Analysis & Opportunity Outlook 2033” delivers a detailed competitors analysis and a detailed overview of the global flash glucose monitoring market in terms of market segmentation by modality, application, technology, end-user, and by region.

Growing Prevalence of Chronic Diseases to Drive Growth of Global Flash Glucose Monitoring Market

The global flash glucose monitoring market is estimated to grow majorly on account of the significantly increasing occurrence of broadly spreading several types of chronic diseases, such as diabetes, and chronic obstructive pulmonary disease. Currently, a huge count of people is dealing with diabetes which require a constant checkup to monitor the blood glucose level. For instance, by the end of 2020, the global occurrence of chronic diseases had increased by approximately 60%.

The market research report also includes other growth factors and challenges that are associated with the growth of the global flash glucose monitoring market. Some of the major growth indicators are:

Growth Drivers:

Globally Escalating Trend of Long-Term Care for Aged People
Significantly Growing Virtual Connectivity

Challenges:

The hurdles of overloaded data associated with the flash glucose monitoring, and stances of skin irritation instigated by these glucose monitoring systems are some of the major factors anticipated to hamper the growth of the global flash glucose monitoring market. Despite of the numerous restraint factors associated with the growth of the market, Research Nester’s analysis indicates a robust growth for the market during the forecast period.

The market research report on global flash glucose monitoring encompasses an in-depth analysis of the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends. These analyses help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future. Additionally, the growth opportunities exposed by the market is poised to gain significant momentum in the next few years.

By end-user, the global flash glucose monitoring market is segmented into hospitals, clinics, academic & research institutes, and others. The hospitals segment is to garner a highest revenue by the end of 2033 by growing at a significant CAGR over the forecast period on the back of the surge in number of people living with diabetes, and potentially growing healthcare spending across the globe.

By region, the North America flash glucose monitoring market is to generate the highest revenue by the end of 2033. This growth is anticipated by the increasing healthcare spending, followed by the transforming lifestyle, and huge upsurge in the number of diabetes cases.

The research is global in nature and covers detailed analysis on the flash glucose monitoring market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

In addition, analysis comprising of global flash glucose monitoring market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

This report also provides the existing competitive scenario of some of the key players of the global flash glucose monitoring market which includes company profiling of Tandem Diabetes Care, Inc., ForaCare, Inc., Novo Nordisk A/S, DexCom, Inc., GlySens Incorporated, Medtronic plc, Insulet Corporation, Ypsomed Holding AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments.

On the whole, the report depicts detailed overview of the global flash glucose monitoring market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.